Zepbound Tracker App
Track Your Zepbound Protocol
Zepbound (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Zepbound protocol — doses, side effects, weight, and labs.
25,000+
Active Users
4.8★
App Rating
Free
Always Free
What Is Zepbound?
Zepbound (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Zepbound protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Zepbound protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Zepbound protocol record from day one.
Dose Log
Record every injection date, dose amount, and administration route.
Weekly Weight
Track body weight consistently to see your response curve over time.
Side Effects
Log any side effects with severity ratings to share with your prescriber.
Lab Results
Save blood work and biomarkers from clinic visits in one place.
Measurements
Waist, hip, and other measurements reveal changes the scale may miss.
Notes & Mood
Daily notes on energy, appetite, sleep, and overall wellbeing.
How to Track Your Zepbound Protocol
Set a baseline: log your starting weight, measurements, and any available labs before your first dose
Record every dose: date, amount, injection site, and any immediate reactions
Log weekly weight at the same time and conditions to track your trend
Note side effects with severity so your prescriber can adjust your protocol
Add lab results from each clinic visit to measure biomarker improvements over time
Zepbound Key Facts
Status
FDA Approved
Approved 2023
Typical Dose
2.5-15 mg/week SC
2.5-15 mg/week SC
Protocol FAQs
Clinical trials showed average weight loss of 22.5% of body weight on the highest dose. Many Shotlee users report losing 50-100+ pounds.
Zepbound comes in 6 doses: 2.5mg (starting), 5mg, 7.5mg, 10mg, 12.5mg, and 15mg (maximum). Doses increase every 4 weeks.
References
- [1]Clinical TrialJastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387(4):327-340.
- [2]FDAFDA. "Zepbound (tirzepatide) injection, for subcutaneous use. Prescribing Information." NDA 215959. 2023.
- [3]Clinical TrialAronne LJ, et al. "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4)." JAMA. 2024;331(1):38-48.
- [4]Clinical TrialGarvey WT, et al. "Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2)." Lancet. 2023;402(10402):613-626.
Track Your Zepbound Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
🚀 Use Shotlee for Free